Difference between revisions of "Muscles Developmental - Pathology"
Jump to navigation
Jump to search
Line 1: | Line 1: | ||
− | |||
− | |||
===[[Myofibrillar Hypoplasia]]=== | ===[[Myofibrillar Hypoplasia]]=== | ||
Line 11: | Line 9: | ||
− | ===Muscular | + | ===[[Muscular Dystrophy]]=== |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
Revision as of 17:29, 3 March 2011
Myofibrillar Hypoplasia
=Muscle Fibre Hyperplasia
Muscular Dystrophy
Glycogen storage diseases
- Caused by a deficiency of an enzyme
- See general pathology
- Type II glycogenosis
- Deficiency of acid maltase
- In Shorthorn cattle
- Muscular weakness and incoordination
- Glycogen stored in skeletal muscle, heart and CNS
- Type I and II muscle fibres contain glycogen vacuoles
- Type III glycogenosis
- Deficiency of debranching enzyme
- In dogs
- Causes hypertrophic cardiomyopathy and hepatomegaly
- Glycogen in skeletal and cardiac muscle, neurons nad hepatocytes
Steatosis
- Also called lipomatosis
- In cattle, sheep and pigs
- Fat replaces lost muscle fibres
- Pale muscle, bilaterally symmetrical
- No clinical significance
- Noticed at slaughter or necropsy
Myasthenia gravis (MG)
- Acquired
- Autoimmune disease
- Antibodies directed against acetyl choline receptors
- Associated with thymomas, megaoesophagus and dysphagia
- In adult dogs
- Autoimmune disease
- Congenital
- Inherited deficiency in acetyl choline receptors
- Rare
- Newfoundland, Jack Russel Terrier, Springer Spaniels – genetic predisposition
- In dogs – 4 DLA genes recognized: DLA-12, DLA-88, DLA-79 and DLA-64
- Associated with HLA gene in humans
- No antibodies against acetyl choline receptors in serum
- Non-specific muscle disuse atrophy and fibrosis or no changes on histology
- Both forms manifest as weakness which worsens on exercise